Physical and Engineering Sciences in Oncology
Page 2

a) The development of novel non-traditional physical and engineering sciences based approaches, materials, or platforms to thoroughly comprehend cancer disorders.

b) The generation of unique sets of physical measurements that are capable of providing insight into molecular mechanisms of oncogenesis, metastasis, drug resistance or other aspects of cancer that could potentially lead to a more effective treatment of the disease.

c) The development and evaluation of theoretical approaches that would provide a comprehensive and dynamic understanding of cancer disorders.

The NSF estimates that it would award 5 to 10 grants to different applicants, with each grant amounting to $2,000,000 to $3,000,000.

The institutions and organizations that will be considered eligible to submit an application for the Physical and Engineering Sciences in Oncology Program are the following:

a) Universities and two- and four-year colleges including community colleges that are located in the United States

b) Non-profit, non-academic organizations such as Independent museums, observatories, research laboratories and professional societies

c) For-profit organizations

d) State, Local, City and Township Governments

e) Unaffiliated Individuals such as Scientists, engineers or educators

f) Foreign organizations

g) Other Federal agencies.


Physical and Engineering Sciences in Oncology
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on community grants and health grants.

Additional Resources

category - Health Grants

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---

Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program
In keeping with this mission, the National Institutes of Health has partnered with the Canadian Institutes of Health Research (CIHR), the National Heart, Lung, and Blood Institute (NHLBI), and the Institute of Circulatory and Respiratory Health (ICRH) to establish the Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program.

---

Minor Use Minor Species Development of Drugs: Research Project Grant
The National Institutes of Health has partnered with the U.S. Food and Drug Administration (FDA) and the Center for Veterinary Medicine(CVM) in an effort to establish the Minor Use Minor Species Development of Drugs: Research Project Grant.

---

Rheumatic Diseases Research Core Centers Project
The National Institutes of Health, in close cooperation with the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), has established a program entitled Rheumatic Diseases Research Core Centers Project wherein they intend to solicit applications for the development of Research Core Centers concentrating on rheumatic diseases.

---